Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hydrogen Sulfide as Prognostic Factor (H2S-1)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Podbregar Matej, University Medical Centre Ljubljana
ClinicalTrials.gov Identifier:
NCT01088490
First received: March 12, 2010
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):